GM and Ford shares fall after UBS downgrades on expectations for weakening demand

Business

In this article

The General Motors world headquarters office is seen at Detroit’s Renaissance Center.
Paul Hennessy | LightRocket | Getty Images

DETROIT — Shares of General Motors and Ford Motor each tumbled Monday after a pair of UBS downgrades citing expectations for weakening demand amid inflationary pressures.

Ford’s stock was down by more than 8% during intraday trading before closing at $11.37 per share, a decline of 6.9%. GM was off by as much as 7.5% before closing at $32.29 per share, down by 4%.

Both GM and Ford shares are off about 45% year to date. Both companies have a market capitalization of just under $50 billion.

UBS analyst Patrick Hummel wrote in notes to investors Monday that he expects the U.S. automotive industry to be challenging for the foreseeable future following record profit amid low supplies and high demand during the coronavirus pandemic.

He predicted “it will take three to six months for the auto industry to end up in oversupply, which will put an abrupt end to a 3-year phase of unprecedented” pricing power and profit margins for the automakers.

The investment firm downgraded Ford to “sell” from “neutral” and GM to “neutral” from “buy.”

UBS continues to prefer GM over Ford due to its momentum with electric vehicles and fewer problems with production during the third quarter. Hummel said UBS expects a “solid quarter” for GM, which is scheduled to report third-quarter results on Oct. 25.

Ford last month said parts shortages have affected roughly 40,000 to 45,000 vehicles, primarily high-margin trucks and SUVs that haven’t been able to reach dealers. Ford also said at the time that it expects to book an extra $1 billion in unexpected supplier costs during the third quarter.

Ford is scheduled to report third-quarter results on Oct. 26.

— CNBC’s Michael Bloom contributed to this report.

Articles You May Like

Medicare Premiums For 2025 Rise 5.9%, Other Out-Of-Pocket Costs Increase
The Medicare Prescription Payment Plan: Yay Or Nay?
We’re changing our price target on TJX despite the retailer’s light guidance
Student loan legal battles delay SAVE borrowers’ path to forgiveness
Act now for $7,500 EV tax credit: There’s ‘real risk’ Trump will axe funding in 2025, lawyer says

Leave a Reply

Your email address will not be published. Required fields are marked *